Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery

• María Jose Rebollo-Lopez,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Joël Lelièvre ,

  * E-mail: joel.l.lelievre@gsk.com (JL); mmarti@pcb.ub.cat (MAMR)

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Daniel Alvarez-Gomez,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Julia Castro-Pichel,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Francisco Martínez-Jiménez,

  Affiliations Genome Biology Group, Centre Nacional d’Anàlisi Genòmica (CNAG), Barcelona, Spain, Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain

  ⨯
• George Papadatos,

  Affiliation European Molecular Biology Laboratory–European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom

  ⨯
• Vinod Kumar,

  Affiliation Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Gonzalo Colmenarejo,

  Affiliation Centro de Investigación Básica, CSci Computational Chemistry, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Grace Mugumbate,

  Affiliation European Molecular Biology Laboratory–European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom

  ⨯
• Mark Hurle,

  Affiliation Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Vanessa Barroso,

  Affiliation Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Rob J. Young,

  Affiliation CSC Medicinal Chemistry, Medicines Research Centre, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom

  ⨯
• María Martinez-Hoyos,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Rubén González del Río,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Robert H. Bates,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Eva Maria Lopez-Roman,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Alfonso Mendoza-Losana,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• James R. Brown,

  Affiliation Computational Biology, Quantitative Sciences, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  ⨯
• Emilio Alvarez-Ruiz,

  Affiliation Centro de Investigación Básica, Platform Technology & Science, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Marc A. Marti-Renom ,

  * E-mail: joel.l.lelievre@gsk.com (JL); mmarti@pcb.ub.cat (MAMR)

  Affiliations Genome Biology Group, Centre Nacional d’Anàlisi Genòmica (CNAG), Barcelona, Spain, Gene Regulation Stem Cells and Cancer Program, Centre for Genomic Regulation (CRG), Barcelona, Spain, Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

  ⨯
• John P. Overington,

  Affiliation European Molecular Biology Laboratory–European Bioinformatics Institute (EMBL-EBI), Hinxton, Cambridge, United Kingdom

  ⨯
• Nicholas Cammack,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Lluís Ballell,

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
•  [ ... ],
• David Barros-Aguire

  Affiliation Diseases of the Developing World, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• [ view all ]
• [ view less ]